2019 Q2 Form 10-Q Financial Statement
#000119312519171334 Filed on June 12, 2019
Income Statement
| Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
|---|---|---|---|
| Revenue | $5.666M | $4.676M | $2.519M |
| YoY Change | 94.37% | 85.63% | |
| Cost Of Revenue | $2.330M | $2.103M | $1.595M |
| YoY Change | 33.91% | 31.85% | |
| Gross Profit | $3.333M | $2.573M | $924.0K |
| YoY Change | 182.7% | 178.46% | |
| Gross Profit Margin | 58.82% | 55.03% | 36.68% |
| Selling, General & Admin | $6.250M | $4.653M | $2.240M |
| YoY Change | 115.52% | 107.72% | |
| % of Gross Profit | 187.52% | 180.84% | 242.42% |
| Research & Development | $4.790M | $3.882M | $3.465M |
| YoY Change | 39.65% | 12.03% | |
| % of Gross Profit | 143.71% | 150.87% | 375.0% |
| Depreciation & Amortization | $280.0K | $245.0K | $166.0K |
| YoY Change | 64.71% | 47.59% | |
| % of Gross Profit | 8.4% | 9.52% | 17.97% |
| Operating Expenses | $11.04M | $8.535M | $5.705M |
| YoY Change | 74.41% | 49.61% | |
| Operating Profit | -$7.705M | -$5.962M | -$4.781M |
| YoY Change | 49.44% | 24.7% | |
| Interest Expense | -$870.0K | $1.093M | $258.0K |
| YoY Change | 17.57% | 323.64% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$1.480M | -$923.0K | -$113.0K |
| YoY Change | 55.63% | 716.81% | |
| Pretax Income | -$9.185M | -$6.885M | -$4.894M |
| YoY Change | 50.4% | 40.68% | |
| Income Tax | $10.00K | $10.00K | $10.00K |
| % Of Pretax Income | |||
| Net Earnings | -$9.195M | -$6.895M | -$4.901M |
| YoY Change | 50.37% | 40.69% | |
| Net Earnings / Revenue | -162.28% | -147.46% | -194.56% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$436.0K | -$340.9K | -$242.1K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 21.09M | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $96.20M | $12.20M | |
| YoY Change | |||
| Cash & Equivalents | $47.24M | $12.22M | $10.30M |
| Short-Term Investments | $49.00M | ||
| Other Short-Term Assets | $1.600M | $1.400M | |
| YoY Change | |||
| Inventory | $11.22M | $11.29M | |
| Prepaid Expenses | |||
| Receivables | $7.105M | $5.146M | |
| Other Receivables | $0.00 | $0.00 | |
| Total Short-Term Assets | $116.1M | $30.06M | |
| YoY Change | |||
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $4.375M | $3.750M | |
| YoY Change | |||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $6.000K | $6.000K | |
| YoY Change | |||
| Total Long-Term Assets | $4.881M | $8.700M | |
| YoY Change | |||
| TOTAL ASSETS | |||
| Total Short-Term Assets | $116.1M | $30.06M | |
| Total Long-Term Assets | $4.881M | $8.700M | |
| Total Assets | $121.0M | $38.76M | |
| YoY Change | |||
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $6.662M | $5.499M | |
| YoY Change | |||
| Accrued Expenses | $8.200M | $10.00M | |
| YoY Change | |||
| Deferred Revenue | $175.0K | $359.0K | |
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $15.38M | $16.20M | |
| YoY Change | |||
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $33.90M | $33.79M | |
| YoY Change | |||
| Other Long-Term Liabilities | $600.0K | $1.300M | |
| YoY Change | |||
| Total Long-Term Liabilities | $33.90M | $33.79M | |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $15.38M | $16.20M | |
| Total Long-Term Liabilities | $33.90M | $33.79M | |
| Total Liabilities | $49.85M | $51.28M | |
| YoY Change | |||
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$342.8M | ||
| YoY Change | |||
| Common Stock | $1.000K | ||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $71.16M | -$199.0M | -$173.6M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $121.0M | $38.76M | |
| YoY Change |
Cashflow Statement
| Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$9.195M | -$6.895M | -$4.901M |
| YoY Change | 50.37% | 40.69% | |
| Depreciation, Depletion And Amortization | $280.0K | $245.0K | $166.0K |
| YoY Change | 64.71% | 47.59% | |
| Cash From Operating Activities | -$12.16M | -$7.266M | -$6.331M |
| YoY Change | 62.78% | 14.77% | |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$150.0K | $3.000K | $40.00K |
| YoY Change | -92.5% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$48.95M | $0.00 | $5.000M |
| YoY Change | -801.29% | -100.0% | |
| Cash From Investing Activities | -$49.10M | -$3.000K | $4.960M |
| YoY Change | -803.44% | -100.06% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | $892.0K | ||
| YoY Change | |||
| Cash From Financing Activities | 96.10M | -697.0K | -880.0K |
| YoY Change | 280.44% | -20.8% | |
| NET CHANGE | |||
| Cash From Operating Activities | -12.16M | -7.266M | -6.331M |
| Cash From Investing Activities | -49.10M | -3.000K | 4.960M |
| Cash From Financing Activities | 96.10M | -697.0K | -880.0K |
| Net Change In Cash | 34.84M | -8.026M | -2.137M |
| YoY Change | 40.65% | 275.57% | |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$12.16M | -$7.266M | -$6.331M |
| Capital Expenditures | -$150.0K | $3.000K | $40.00K |
| Free Cash Flow | -$12.01M | -$7.269M | -$6.371M |
| YoY Change | 60.78% | 14.1% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
33670000 | |
| CY2019Q1 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
667000 | |
| CY2018Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
759000 | |
| CY2018Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
306000 | |
| CY2019Q1 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
354000 | |
| CY2018Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
349000 | |
| CY2019Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
16201000 | |
| CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
12553000 | |
| CY2019Q1 | tmdx |
Preferred Stock Warrants And Rights Outstanding
PreferredStockWarrantsAndRightsOutstanding
|
625000 | |
| CY2018Q4 | tmdx |
Preferred Stock Warrants And Rights Outstanding
PreferredStockWarrantsAndRightsOutstanding
|
898000 | |
| CY2019Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
33785000 | |
| CY2019Q1 | us-gaap |
Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
|
1.00 | |
| CY2019Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
4179000 | |
| CY2018 | us-gaap |
Profit Loss
ProfitLoss
|
23800000 | |
| CY2019Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12215000 | |
| CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
20241000 | |
| CY2019Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5146000 | |
| CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
3438000 | |
| CY2019Q1 | us-gaap |
Inventory Net
InventoryNet
|
11294000 | |
| CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
9277000 | |
| CY2019Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1404000 | |
| CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1838000 | |
| CY2018Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
3817000 | |
| CY2019Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
1097000 | |
| CY2018Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
882000 | |
| CY2019Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
6018000 | |
| CY2018Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
4578000 | |
| CY2019Q1 | us-gaap |
Inventory Net
InventoryNet
|
11294000 | |
| CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
9277000 | |
| CY2019Q1 | us-gaap |
Assets Current
AssetsCurrent
|
30059000 | |
| CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
34794000 | |
| CY2019Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3750000 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3474000 | |
| CY2019Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
4444000 | |
| CY2018Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
3383000 | |
| CY2019Q1 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
500000 | |
| CY2018Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
500000 | |
| CY2019Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6000 | |
| CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6000 | |
| CY2019Q1 | us-gaap |
Assets
Assets
|
38759000 | |
| CY2018Q4 | us-gaap |
Assets
Assets
|
42157000 | |
| CY2019Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5499000 | |
| CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4720000 | |
| CY2019Q1 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
9989000 | |
| CY2018Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
7178000 | |
| CY2019Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
359000 | |
| CY2019Q1 | us-gaap |
Liabilities
Liabilities
|
51278000 | |
| CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
47880000 | |
| CY2019Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
186519000 | |
| CY2019Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
| CY2019Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
143859000 | |
| CY2019Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2491000 | |
| CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1729000 | |
| CY2019Q1 | tmdx |
Accrued Financing Fees Current
AccruedFinancingFeesCurrent
|
1466000 | |
| CY2018Q4 | tmdx |
Accrued Financing Fees Current
AccruedFinancingFeesCurrent
|
1466000 | |
| CY2019Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1002000 | |
| CY2018Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
549000 | |
| CY2018Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
186519000 | |
| CY2019Q1 | tmdx |
Accrued Premium For Manufacturing Contract Current
AccruedPremiumForManufacturingContractCurrent
|
1067000 | |
| CY2018Q4 | tmdx |
Accrued Premium For Manufacturing Contract Current
AccruedPremiumForManufacturingContractCurrent
|
1089000 | |
| CY2019Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1383000 | |
| CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
492000 | |
| CY2019Q1 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
9989000 | |
| CY2018Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
7178000 | |
| CY2019Q1 | us-gaap |
Revenues
Revenues
|
4676000 | |
| CY2018Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
143794000 | |
| CY2019Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-67000 | |
| CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-101000 | |
| CY2019Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-342831000 | |
| CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-335936000 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-199038000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-192242000 | |
| CY2019Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
38759000 | |
| CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
42157000 | |
| CY2019Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
35000000 | |
| CY2018Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
35000000 | |
| CY2019Q1 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
4655000 | |
| CY2019Q1 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
4655000 | |
| CY2018Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
13586000 | |
| CY2018Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
13586000 | |
| CY2019Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q1 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1355000 | |
| CY2018Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1424000 | |
| CY2019Q1 | us-gaap |
Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid
DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
|
140000 | |
| CY2018Q4 | us-gaap |
Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid
DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
|
94000 | |
| CY2019Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
33785000 | |
| CY2018Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
33670000 | |
| CY2019Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1426980 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1426673 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1397800 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1397493 | |
| CY2019Q1 | tmdx |
Schedule Of Accrued Expenses And Other Current Liabilities
ScheduleOfAccruedExpensesAndOtherCurrentLiabilities
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 6pt; text-indent: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses and other current liabilities consisted of the following (in thousands): </div></div><div style="font-family: "times new roman", serif; font-size: 12pt; margin-bottom: 0px; margin-top: 0px; background: none;"><div style="font-family: "times new roman", serif; font-size: 12pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 76%;;margin : 0px auto;;text-align:left;;margin-left :auto;margin-right :auto;"><tr><td style="border-bottom: none; border-top: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-size: 8pt; line-height: normal; background: none; text-align: center; font-family: "times new roman", times, serif;"><div style="font-size: 8pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px; font-family: "times new roman", times, serif;;display:inline;"> </div></div></td><td style="border-top: none; padding: 0in 0in 1pt; vertical-align: bottom;;width:;"><div style="font-size: 8pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 8pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap;;width:;"><div style="font-size: 8pt; text-align: center; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 8pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">March 30, 2019</div></div></div></td><td style="border-top: none; padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap;"><div style="font-size: 8pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 8pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-top: none; padding: 0in 0in 1pt; vertical-align: bottom; white-space: nowrap;;width:;"><div style="font-size: 8pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 8pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap;;width:;"><div style="font-size: 8pt; text-align: center; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif;"><div style="font-family: "times new roman", times, serif; font-size: 8pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="white-space: nowrap;;font-weight:bold;display:inline;">December 29, 2018</div></div></div></td><td style="border-top: none; padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap;"><div style="font-size: 8pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 8pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; width: 80%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.17in; margin-top: 0px; text-indent: -0.17in; line-height: normal;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accrued research, development and clinical trials expenses</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 0.5%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; text-align: left; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">2,580</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 12%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; text-align: left; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: 0px none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,853</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 0.5%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 80%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.17in; margin-top: 0px; text-indent: -0.17in; line-height: normal;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accrued payroll and related expenses</div></div></td><td style="padding: 0in; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 0.5%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">2,491</div></div></td><td style="padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 12%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,729</div></div></td><td style="padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 0.5%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; width: 80%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.17in; margin-top: 0px; text-indent: -0.17in; line-height: normal;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accrued financing fees (Note 9)</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 0.5%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,466</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 12%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,466</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 0.5%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 80%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.17in; margin-top: 0px; text-indent: -0.17in; line-height: normal;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accrued professional fees</div></div></td><td style="padding: 0in; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 0.5%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,002</div></div></td><td style="padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 12%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">549</div></div></td><td style="padding: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 0.5%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0px; vertical-align: bottom; width: 80%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.17in; margin-top: 0px; text-indent: -0.17in; line-height: normal;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accrued premium for manufacturing contract</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 0.5%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,067</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 12%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0in; vertical-align: bottom; white-space: nowrap; width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,089</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; white-space: nowrap; width: 0.5%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="border-bottom: none; border-top: none; padding: 0px 0px 0.5pt; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 80%;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.17in; margin-top: 0px; text-indent: -0.17in; line-height: normal;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accrued other</div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 0.5%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 1pt solid black; border-top: none; text-align: left; vertical-align: bottom; padding-top: 0in; padding-right: 0in; padding-left: 0in;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: 1pt solid black; border-top: none; padding-top: 0in; padding-right: 0in; padding-left: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,383</div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(255, 255, 255); width: 12%; vertical-align: bottom; padding: 0in 0in 0.5pt;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: 1pt solid black; border-top: none; padding-top: 0in; padding-right: 0in; padding-left: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-bottom: 1pt solid black; border-top: none; padding-top: 0in; padding-right: 0in; padding-left: 0in; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">492</div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255); width: 0.5%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-bottom: none; border-top: none; padding: 0px 0px 1.25pt; vertical-align: bottom; width: 80%;"><div style="font-size: 10pt; line-height: normal; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: "times new roman", times, serif;"> </div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 0.5%;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 2.5pt double black; border-top: none; text-align: left; vertical-align: bottom; padding-top: 0in; padding-right: 0in; padding-left: 0in;"><div style="font-size: 10pt; text-align: left; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double black; border-top: none; padding-top: 0in; padding-right: 0in; padding-left: 0in; vertical-align: bottom; white-space: nowrap; width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">9,989</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background-color: rgb(204, 238, 255); width: 12%; vertical-align: bottom; padding: 0in 0in 1.25pt;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double black; border-top: none; padding-top: 0in; padding-right: 0in; padding-left: 0in; vertical-align: bottom; white-space: nowrap; width: 1%; text-align: left;"><div style="font-size: 10pt; text-align: left; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double black; border-top: none; padding-top: 0in; padding-right: 0in; padding-left: 0in; vertical-align: bottom; white-space: nowrap; width: 2%; text-align: right;"><div style="font-size: 10pt; text-align: right; line-height: normal; white-space: nowrap; font-family: "times new roman", times, serif; margin-right: 0in;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">7,178</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; white-space: nowrap; width: 0.5%; text-align: left;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr></table><div style="clear: both; max-height: 0px;"> </div><div style="clear: both; max-height: 0px;"> </div><div style="clear: both; max-height: 0px;"> </div><div style="clear: both; max-height: 0px;"> </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2019Q1 | tmdx |
Accrued Research Development And Clinical Trials Expenses Current
AccruedResearchDevelopmentAndClinicalTrialsExpensesCurrent
|
2580000 | |
| CY2018Q4 | tmdx |
Accrued Research Development And Clinical Trials Expenses Current
AccruedResearchDevelopmentAndClinicalTrialsExpensesCurrent
|
1853000 | |
| CY2018Q1 | us-gaap |
Revenues
Revenues
|
2519000 | |
| CY2019Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2103000 | |
| CY2018Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1595000 | |
| CY2019Q1 | us-gaap |
Gross Profit
GrossProfit
|
2573000 | |
| CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
924000 | |
| CY2019Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3882000 | |
| CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3465000 | |
| CY2019Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4653000 | |
| CY2018Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2240000 | |
| CY2019Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
8535000 | |
| CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
5705000 | |
| CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5962000 | |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4781000 | |
| CY2019Q1 | us-gaap |
Interest Expense
InterestExpense
|
1093000 | |
| CY2018Q1 | us-gaap |
Interest Expense
InterestExpense
|
258000 | |
| CY2019Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-273000 | |
| CY2018Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
30000 | |
| CY2019Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-103000 | |
| CY2018Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
175000 | |
| CY2019Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-923000 | |
| CY2018Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-113000 | |
| CY2019Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-6885000 | |
| CY2018Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4894000 | |
| CY2019Q1 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
10000 | |
| CY2018Q1 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
7000 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-4.86 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.61 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1418353 | |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1358694 | |
| CY2019Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50776054 | |
| CY2019Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
50404140 | |
| CY2019Q1 | us-gaap |
Preferred Stock Value Outstanding
PreferredStockValueOutstanding
|
186519000 | |
| CY2019Q1 | us-gaap |
Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
|
London Interbank Offered Rate (“LIBOR”), subject to a minimum of 1.0% and a maximum of 4.0% | |
| CY2019Q1 | us-gaap |
Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
|
0.085 | |
| CY2019Q1 | tmdx |
Prepayment Premium Percentage
PrepaymentPremiumPercentage
|
0.090 | |
| CY2019Q1 | us-gaap |
Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
|
The covenants include maintaining a minimum liquidity amount of $3.0 million; the requirement, on an annual basis, to deliver to OrbiMed annual audited financial statements with an unqualified audit opinion from the Company’s independent registered public accounting firm; and restrictions on the Company’s activities, including limitations on dispositions, mergers or acquisitions; encumbering its intellectual property; incurring indebtedness or liens; paying dividends; making certain investments; and engaging in certain other business transactions. | |
| CY2019Q1 | us-gaap |
Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
|
0.131 | |
| CY2019Q1 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.113 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6895000 | |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4901000 | |
| CY2019Q1 | us-gaap |
Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
|
223681000 | |
| CY2019Q1 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
13119424 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
34000 | |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-6000 | |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
4000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
34000 | |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-2000 | |
| CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-6861000 | |
| CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-4903000 | |
| CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
57000 | |
| CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
27000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-192242000 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
8000 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
57000 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-199038000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-168724000 | |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
12000 | |
| CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
27000 | |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-173588000 | |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
4000 | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
1162000 | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
1570000 | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
1589000 | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
4321000 | |
| CY2019Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
300000 | |
| CY2018Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
300000 | |
| CY2016Q4 | tmdx |
Accrued Financing Fees Current
AccruedFinancingFeesCurrent
|
1500000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6895000 | |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4901000 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1418353 | |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1358694 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-4.86 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.61 | |
| CY2019Q1 | us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.10 | |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14779014 | |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14735248 | |
| CY2019Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-6895000 | |
| CY2018Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-4901000 | |
| CY2019Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
245000 | |
| CY2018Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
166000 | |
| CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
57000 | |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
27000 | |
| CY2019Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-273000 | |
| CY2018Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
30000 | |
| CY2019Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
115000 | |
| CY2018Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
60000 | |
| CY2018Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
9000 | |
| CY2019Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-160000 | |
| CY2018Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
143000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1746000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1021000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2468000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1178000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-417000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
143000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
758000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-843000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
2394000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1692000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
57000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-4000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
87000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
82000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7266000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6331000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3000 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
40000 | |
| CY2018Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
5000000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
4960000 | |
| CY2018Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
892000 | |
| CY2019Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
705000 | |
| CY2019Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
8000 | |
| CY2018Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
12000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-697000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-880000 | |
| CY2019Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-60000 | |
| CY2018Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
114000 | |
| CY2019Q1 | tmdx |
Inventory Transfer To Property Plant And Equipment
InventoryTransferToPropertyPlantAndEquipment
|
407000 | |
| CY2018Q1 | tmdx |
Inventory Transfer To Property Plant And Equipment
InventoryTransferToPropertyPlantAndEquipment
|
342000 | |
| CY2019Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
129000 | |
| CY2018Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
4000 | |
| CY2019Q1 | tmdx |
Deferred Offering Costs Included In Accounts Payable And Accrued Expenses
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
1134000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6895000 | |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4901000 | |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2137000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
20741000 | |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12436000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12715000 | |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10299000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-8026000 | |
| CY2019Q1 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
3750 | |
| CY2018Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
3474 | |
| CY2019Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 18pt; margin-left: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 6pt; text-indent: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, revenue recognition, the valuation of inventory, the valuation of common stock, the valuation of stock-based awards and the valuation of the preferred stock warrant liability. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2019Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 18pt; margin-left: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Risk of Concentrations of Credit, Significant Customers and Significant Suppliers </div></div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 6pt; text-indent: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company has not experienced any other-than-temporary losses with respect to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. </div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 12pt; text-indent: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Significant customers are those that accounted for 10% or more of the Company’s total revenue or accounts receivable (see Note 12). </div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 12pt; text-indent: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Certain of the components and subassemblies included in the Company’s products are obtained from a sole source, a single source or a limited group of suppliers. Although the Company seeks to reduce dependence on those limited sources of suppliers and manufacturers, the partial or complete loss of certain of these sources could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | |
| CY2019Q1 | tmdx |
Balloon Payment To Be Paid Percentage
BalloonPaymentToBePaidPercentage
|
0.030 | |
| CY2019Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
21093654 | |
| CY2019Q1 | tmdx |
Convertible Preferred Stock Conversion Ratio
ConvertiblePreferredStockConversionRatio
|
3.5-for-one | |
| CY2019Q1 | us-gaap |
Revenues
Revenues
|
4676000 | |
| CY2018Q1 | us-gaap |
Revenues
Revenues
|
2519000 | |
| CY2019Q1 | tmdx |
Clinical Trial Expense
ClinicalTrialExpense
|
614000 | |
| CY2018Q1 | tmdx |
Clinical Trial Expense
ClinicalTrialExpense
|
237000 | |
| CY2019Q1 | us-gaap |
Revenues
Revenues
|
4676000 | |
| CY2018Q1 | us-gaap |
Revenues
Revenues
|
2519000 | |
| CY2019Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
700000 | |
| CY2018Q4 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
1500000 | |
| CY2018Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2756000 | |
| CY2019Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
5290000 | |
| CY2019Q1 | tmdx |
Research Development And Clinical Trials Expenses
ResearchDevelopmentAndClinicalTrialsExpenses
|
200000 | |
| CY2019Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2019Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2019Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2019-03-30 | |
| CY2019Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2019 | |
| CY2019Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2019Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
TransMedics Group, Inc. | |
| CY2019Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001756262 | |
| CY2019Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-28 | |
| CY2019Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | |
| CY2019Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
| CY2019Q1 | dei |
Trading Symbol
TradingSymbol
|
TMDX | |
| CY2019Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2019Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
| CY2019Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
| CY2019Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true |
